Big Biotech In The CRISPR Game: Novartis And Vertex Lead The Pack – Seeking Alpha
|
Big Biotech In The CRISPR Game: Novartis And Vertex Lead The Pack
Seeking Alpha CRISPR Therapeutics and Intellia Therapeutics are partnered with the strongest large biotech plays in the space in Vertex and Novartis respectively. NVS will maintain a significant leading role in CAR-T engineering with NTLA's CRISPR technologies … |
